Abstract:OBJECTIVES
To evaluate the hemodynamicdynamic advantage of a new Fontan surgical template that is intended for complex single-ventricle patients with interrupted inferior vena cava-azygos and hemi-azygos continuation. The new technique has emerged from a comprehensive pre-surgical simulation campaign conducted to facilitate a balanced hepatic flow and somatic Fontan pathway growth after Kawashima procedure.
METHODS
For 9 pati… Show more
“…Pre-surgical simulations carried out on 9 individuals in Lashkarinia et al 's Y transplant fontan study [13] revealed that flow from the hepatic veins (HEP) was not reaching the target lung. The HEP flow to the target lung was dramatically increased by the innovative Y-graft template.…”
Background
Achieving optimal hepatic factor distribution and total cavopulmonary resistance is crucial for long-term outcomes in single ventricle palliation patients. Y-shaped Gore-Tex Fontan procedure redirects hepatic drainage to both the right and left pulmonary arteries. The aim of this approach is to achieve bilateral pulmonary distribution of hepatic factors and reduce the risk of arteriovenous malformations that can develop in single-ventricle patients.
Case presentation
We present a unique case of a 20 years old female with symptoms of heart failure, who has a history of complex heterotaxy with polysplenia, interrupted Inferior vena-cava, and double outlet right ventricle with unbalanced atrio-ventricular septal defect, d-malposed great arteries, and pulmonary atresia. Fenestrated Y-shaped Gore-Tex Fontan procedure was successfully done which was confirmed by performing cardiac CT angiography.
Conclusions
Studies have shown that achieving balanced hepatic factor distribution and low resistance in the Fontan pathway can improve long-term outcomes. This procedure has demonstrated positive results in terms of oxygen saturation and reduced asymmetric blood flow distribution.
Level of Evidence
Level 4, Case Report.
“…Pre-surgical simulations carried out on 9 individuals in Lashkarinia et al 's Y transplant fontan study [13] revealed that flow from the hepatic veins (HEP) was not reaching the target lung. The HEP flow to the target lung was dramatically increased by the innovative Y-graft template.…”
Background
Achieving optimal hepatic factor distribution and total cavopulmonary resistance is crucial for long-term outcomes in single ventricle palliation patients. Y-shaped Gore-Tex Fontan procedure redirects hepatic drainage to both the right and left pulmonary arteries. The aim of this approach is to achieve bilateral pulmonary distribution of hepatic factors and reduce the risk of arteriovenous malformations that can develop in single-ventricle patients.
Case presentation
We present a unique case of a 20 years old female with symptoms of heart failure, who has a history of complex heterotaxy with polysplenia, interrupted Inferior vena-cava, and double outlet right ventricle with unbalanced atrio-ventricular septal defect, d-malposed great arteries, and pulmonary atresia. Fenestrated Y-shaped Gore-Tex Fontan procedure was successfully done which was confirmed by performing cardiac CT angiography.
Conclusions
Studies have shown that achieving balanced hepatic factor distribution and low resistance in the Fontan pathway can improve long-term outcomes. This procedure has demonstrated positive results in terms of oxygen saturation and reduced asymmetric blood flow distribution.
Level of Evidence
Level 4, Case Report.
“…Total energy loss (EL) is an emerging clinical hemodynamic parameter representing the pulsatile energy lost due to the blood flow as it flows through the cardiovascular component volume. It is utilized routinely in the pre-surgical planning of Fontan conduits [ 6 ]. 4D flow MRI is a useful tool to estimate the EL in the Fontan system and can explain the cause of FF [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Here, we present a case with FF presenting with severe ascites. Although echocardiography and cardiac catheterization show normal findings, an interventional approach was initiated and judged according to the comparative EL levels calculated with 4D flow MRI [ 6 , 8 , 9 ].…”
“…As the population of late survivors with Fontan circulation continues to grow and donor organ shortages persist, the management of Fontan failure has become a signi cant clinical challenge, and innovative strategies are urgently required [15]. Attempts aimed at addressing the Fontan paradox have primarily focused on optimizing the TCPC anatomy to improve blood energetics through novel surgical pathways, such as Y-grafts [16][17][18][19][20][21]. These modi cations, however, fail to address the physiologic de cit of a ventricle as the right-side driving pump and thus have little impact on the Fontan outcomes [22].…”
Univentricular heart anomalies represent a group of severe congenital heart defects necessitating early surgical intervention in infancy. The Fontan procedure, the final stage of single-ventricle palliation, establishes a serial connection between systemic and pulmonary circulation by channeling venous return to the lungs. The absence of the subpulmonary ventricle in this peculiar circulation progressively eventuates in failure, primarily due to chronic elevation in inferior vena cava (IVC) pressure. This study experimentally validates the effectiveness of an intracorporeally-powered venous ejector pump (VEP) in reducing IVC pressure in Fontan patients. The VEP exploits a fraction of aortic flow to create a jet-venturi effect for the IVC, negating the external power requirement and driveline infections. A multi-scale in-vitro Fontan mock-up circulation loop is developed and the impact of VEP design parameters and physiological conditions is assessed using both idealized and patient-specific total cavopulmonary connection (TCPC) phantoms. The VEP performance in reducing IVC pressure exhibited an inverse relationship with the cardiac output and extra-cardiac conduit (ECC) size and a proportional relationship with the transpulmonary pressure gradient (TPG) and mean arterial pressure (MAP). The ideal VEP with fail-safe features provided an IVC pressure drop of 1.82 ± 0.49, 2.45 ± 0.54, and 3.12 ± 0.43 mm Hg for TPG values of 6, 8, and 10 mm Hg, respectively, averaged over all ECC sizes and cardiac outputs. Furthermore, the arterial oxygen saturation was consistently maintained above 85% in all conditions. These results emphasize the potential utility of the VEP to mitigate elevated venous pressure in Fontan patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.